Skip to main content
. 2018 Aug 6;19(9):668–672. doi: 10.1111/hiv.12642

Table 1.

Cohort characteristics (n = 112)

Current age (years) [median (IQR)] 15.4 (12.6–16.8)
Sex [n (%)]
Female 65 (58)
Male 47 (42)
Ethnicity [n (%)]
Black African 86 (76.8)
Black other 13 (11.6)
Caucasian 6 (5.4)
Caucasian, South East Asian 4 (3.6)
South Asian 3 (2.7)
Current ART therapy [n (%)]
On ART 105 (93.8)
Not on ART 7 (6.3)
First‐line ART [n (%)] 48 (51.6)
Other ART [n (%)] 45 (48.4)
Age (months) at start of ART [median (IQR)] (n = 93) 39.8 (5.6–103.4)
Length of follow‐up from start of ART (months) [median (IQR)] (n = 89) 128 (59–161)
CD4:CD8 ratio ≤ 0.4 [n (%)] 11 (9.8)

ART, antiretroviral therapy; IQR, interquartile range.